18 June 2024 false No description of principal activity Taxfiler 2024.6 15787029 business:PrivateLimitedCompanyLtd 2024-06-18 2025-06-30 15787029 2024-06-17 15787029 2024-06-18 2025-06-30 15787029 business:AuditExemptWithAccountantsReport 2024-06-18 2025-06-30 15787029 business:FilletedAccounts 2024-06-18 2025-06-30 15787029 2025-06-30 15787029 business:Director1 2024-06-18 2025-06-30 15787029 business:CompanySecretary1 2024-06-18 2025-06-30 15787029 business:RegisteredOffice 2024-06-18 2025-06-30 15787029 core:WithinOneYear 2025-06-30 15787029 core:ShareCapital core:PreviouslyStatedAmount 2025-06-30 15787029 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-06-30 15787029 core:PreviouslyStatedAmount 2025-06-30 15787029 business:SmallEntities 2024-06-18 2025-06-30 15787029 countries:EnglandWales 2024-06-18 2025-06-30 15787029 core:PlantMachinery 2024-06-18 2025-06-30 15787029 core:MotorVehicles 2024-06-18 2025-06-30 15787029 core:FurnitureFittings 2024-06-18 2025-06-30 15787029 core:ComputerEquipment 2024-06-18 2025-06-30 15787029 core:MotorVehicles 2024-06-17 15787029 core:MotorVehicles 2025-06-30 iso4217:GBP xbrli:pure
Company Registration No. 15787029 (England and Wales)
Emmacopharma Limited Unaudited accounts for the period from 18 June 2024 to 30 June 2025
Emmacopharma Limited Unaudited accounts Contents
Page
Company information
3
Statement of financial position
4
Notes to the accounts
5
- 2 -
Emmacopharma Limited Company Information for the period from 18 June 2024 to 30 June 2025
Director
Theresa Martey
Secretary
Theresa Martey
Company Number
15787029 (England and Wales)
Registered Office
1 Carnegie Close Enfield Middlesex EN3 6XX England
Accountants
PMCT Accountants & Consultants Ability House 121 Brooker Road Waltham Abbey Essex EN9 1JH
- 3 -
Emmacopharma Limited Statement of financial position as at 30 June 2025
2025
Notes
£
Fixed assets
Tangible assets
4
5,561
Current assets
Cash at bank and in hand
24,833
Creditors: amounts falling due within one year
5
(12,769)
Net current assets
12,064
Net assets
17,625
Capital and reserves
Called up share capital
1,000
Profit and loss account
16,625
Shareholders' funds
17,625
For the period ending 30 June 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 26 February 2026 and were signed on its behalf by
Theresa Martey Director Company Registration No. 15787029
- 4 -
Emmacopharma Limited Notes to the Accounts for the period from 18 June 2024 to 30 June 2025
1
Statutory information
Emmacopharma Limited is a private company, limited by shares, registered in England and Wales, registration number 15787029. The registered office is 1 Carnegie Close, Enfield, Middlesex, EN3 6XX, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
18%
Motor vehicles
18%
Fixtures & fittings
18%
Computer equipment
18%
4
Tangible fixed assets
Motor vehicles
£
Cost or valuation
At cost
At 18 June 2024
-
Additions
6,782
At 30 June 2025
6,782
Depreciation
Charge for the period
1,221
At 30 June 2025
1,221
Net book value
At 30 June 2025
5,561
5
Creditors: amounts falling due within one year
2025
£
Taxes and social security
10,981
Other creditors
1,788
12,769
- 5 -
Emmacopharma Limited Notes to the Accounts for the period from 18 June 2024 to 30 June 2025
6
Average number of employees
During the period the average number of employees was 1.
- 6 -